Cargando…

Structural basis of nSH2 regulation and lipid binding in PI3Kα

We report two crystal structures of the wild-type phosphatidylinositol 3-kinase α (PI3Kα) heterodimer refined to 2.9 Å and 3.4 Å resolution: the first as the free enzyme, the second in complex with the lipid substrate, diC4-PIP(2), respectively. The first structure shows key interactions of the N-te...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Michelle S., Schmidt-Kittler, Oleg, Bolduc, David M., Brower, Evan T., Chaves-Moreira, Daniele, Allaire, Marc, Kinzler, Kenneth W., Jennings, Ian G., Thompson, Philip E., Cole, Philip A., Amzel, L. Mario, Vogelstein, Bert, Gabelli, Sandra B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170646/
https://www.ncbi.nlm.nih.gov/pubmed/25105564
_version_ 1782335842488942592
author Miller, Michelle S.
Schmidt-Kittler, Oleg
Bolduc, David M.
Brower, Evan T.
Chaves-Moreira, Daniele
Allaire, Marc
Kinzler, Kenneth W.
Jennings, Ian G.
Thompson, Philip E.
Cole, Philip A.
Amzel, L. Mario
Vogelstein, Bert
Gabelli, Sandra B.
author_facet Miller, Michelle S.
Schmidt-Kittler, Oleg
Bolduc, David M.
Brower, Evan T.
Chaves-Moreira, Daniele
Allaire, Marc
Kinzler, Kenneth W.
Jennings, Ian G.
Thompson, Philip E.
Cole, Philip A.
Amzel, L. Mario
Vogelstein, Bert
Gabelli, Sandra B.
author_sort Miller, Michelle S.
collection PubMed
description We report two crystal structures of the wild-type phosphatidylinositol 3-kinase α (PI3Kα) heterodimer refined to 2.9 Å and 3.4 Å resolution: the first as the free enzyme, the second in complex with the lipid substrate, diC4-PIP(2), respectively. The first structure shows key interactions of the N-terminal SH2 domain (nSH2) and iSH2 with the activation loop that suggest a mechanism by which the enzyme is inhibited in its basal state. In the second structure, the lipid substrate binds in a positively charged pocket adjacent to the ATP-binding site, bordered by the P-loop, the activation loop and the iSH2 domain. An additional lipid-binding site was identified at the interface of the ABD, iSH2 and kinase domains. The ability of PI3Kα to bind an additional PIP(2) molecule was confirmed in vitro by fluorescence quenching experiments. The crystal structures reveal key differences in the way the nSH2 domain interacts with wild-type p110α and with the oncogenic mutant p110αH1047R. Increased buried surface area and two unique salt-bridges observed only in the wild-type structure suggest tighter inhibition in the wild-type PI3Kα than in the oncogenic mutant. These differences may be partially responsible for the increased basal lipid kinase activity and increased membrane binding of the oncogenic mutant.
format Online
Article
Text
id pubmed-4170646
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-41706462014-09-22 Structural basis of nSH2 regulation and lipid binding in PI3Kα Miller, Michelle S. Schmidt-Kittler, Oleg Bolduc, David M. Brower, Evan T. Chaves-Moreira, Daniele Allaire, Marc Kinzler, Kenneth W. Jennings, Ian G. Thompson, Philip E. Cole, Philip A. Amzel, L. Mario Vogelstein, Bert Gabelli, Sandra B. Oncotarget Priority Research Paper We report two crystal structures of the wild-type phosphatidylinositol 3-kinase α (PI3Kα) heterodimer refined to 2.9 Å and 3.4 Å resolution: the first as the free enzyme, the second in complex with the lipid substrate, diC4-PIP(2), respectively. The first structure shows key interactions of the N-terminal SH2 domain (nSH2) and iSH2 with the activation loop that suggest a mechanism by which the enzyme is inhibited in its basal state. In the second structure, the lipid substrate binds in a positively charged pocket adjacent to the ATP-binding site, bordered by the P-loop, the activation loop and the iSH2 domain. An additional lipid-binding site was identified at the interface of the ABD, iSH2 and kinase domains. The ability of PI3Kα to bind an additional PIP(2) molecule was confirmed in vitro by fluorescence quenching experiments. The crystal structures reveal key differences in the way the nSH2 domain interacts with wild-type p110α and with the oncogenic mutant p110αH1047R. Increased buried surface area and two unique salt-bridges observed only in the wild-type structure suggest tighter inhibition in the wild-type PI3Kα than in the oncogenic mutant. These differences may be partially responsible for the increased basal lipid kinase activity and increased membrane binding of the oncogenic mutant. Impact Journals LLC 2014-07-25 /pmc/articles/PMC4170646/ /pubmed/25105564 Text en Copyright: © 2014 Miller et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Priority Research Paper
Miller, Michelle S.
Schmidt-Kittler, Oleg
Bolduc, David M.
Brower, Evan T.
Chaves-Moreira, Daniele
Allaire, Marc
Kinzler, Kenneth W.
Jennings, Ian G.
Thompson, Philip E.
Cole, Philip A.
Amzel, L. Mario
Vogelstein, Bert
Gabelli, Sandra B.
Structural basis of nSH2 regulation and lipid binding in PI3Kα
title Structural basis of nSH2 regulation and lipid binding in PI3Kα
title_full Structural basis of nSH2 regulation and lipid binding in PI3Kα
title_fullStr Structural basis of nSH2 regulation and lipid binding in PI3Kα
title_full_unstemmed Structural basis of nSH2 regulation and lipid binding in PI3Kα
title_short Structural basis of nSH2 regulation and lipid binding in PI3Kα
title_sort structural basis of nsh2 regulation and lipid binding in pi3kα
topic Priority Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170646/
https://www.ncbi.nlm.nih.gov/pubmed/25105564
work_keys_str_mv AT millermichelles structuralbasisofnsh2regulationandlipidbindinginpi3ka
AT schmidtkittleroleg structuralbasisofnsh2regulationandlipidbindinginpi3ka
AT bolducdavidm structuralbasisofnsh2regulationandlipidbindinginpi3ka
AT browerevant structuralbasisofnsh2regulationandlipidbindinginpi3ka
AT chavesmoreiradaniele structuralbasisofnsh2regulationandlipidbindinginpi3ka
AT allairemarc structuralbasisofnsh2regulationandlipidbindinginpi3ka
AT kinzlerkennethw structuralbasisofnsh2regulationandlipidbindinginpi3ka
AT jenningsiang structuralbasisofnsh2regulationandlipidbindinginpi3ka
AT thompsonphilipe structuralbasisofnsh2regulationandlipidbindinginpi3ka
AT colephilipa structuralbasisofnsh2regulationandlipidbindinginpi3ka
AT amzellmario structuralbasisofnsh2regulationandlipidbindinginpi3ka
AT vogelsteinbert structuralbasisofnsh2regulationandlipidbindinginpi3ka
AT gabellisandrab structuralbasisofnsh2regulationandlipidbindinginpi3ka